101
|
Canadian Contraception Consensus Chapter 2 Contraceptive Care and Access. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA 2015; 37:S13-S19. [DOI: 10.1016/s1701-2163(16)39371-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
102
|
Morhason-Bello IO, Wallis S, Adedokun BO, Adewole IF. Willingness of reproductive-aged women in a Nigerian community to accept human papillomavirus vaccination for their children. J Obstet Gynaecol Res 2015; 41:1621-9. [DOI: 10.1111/jog.12775] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Accepted: 05/08/2015] [Indexed: 12/11/2022]
Affiliation(s)
- Imran O. Morhason-Bello
- Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medicine; University of Ibadan/University College Hospital; Ibadan Nigeria
| | - Selina Wallis
- Liverpool School of Tropical Medicine; University of Liverpool; Liverpool United Kingdom
| | - Babatunde O. Adedokun
- Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine; University of Ibadan; Ibadan Nigeria
| | - Isaac F. Adewole
- Department of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medicine; University of Ibadan/University College Hospital; Ibadan Nigeria
| |
Collapse
|
103
|
Lee Mortensen G, Adam M, Idtaleb L. Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey. BMC Public Health 2015; 15:624. [PMID: 26152138 PMCID: PMC4495645 DOI: 10.1186/s12889-015-1863-6] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Accepted: 05/22/2015] [Indexed: 12/11/2022] Open
Abstract
Background Human papillomavirus (HPV) is a common sexually transmitted virus that can lead to severe diseases in both women and men. Today, HPV vaccination is offered to females only across Europe. We aimed to examine parental attitudes to HPV vaccination of their sons given brief information about HPV in both genders. Methods A literature study on acceptability of male HPV vaccination was carried out to inform the construction of a study questionnaire. Following up on a Danish study from 2012, this questionnaire was applied in 1837 computer assisted interviews with parents of sons in the UK, Germany, France and Italy. In each country, the parents were representative in terms of geographical dispersion, city size and age of sons in the household. The applied questionnaires took the varying vaccination policies and delivery systems into account. The data were analysed pooled and for each country using significant statistical tests (chi-2) with a 95 % confidence interval. Results Approximately ¾ of parents in the UK, Germany and Italy were in favour of HPV vaccination of their sons. In France, this applied to 49 % of respondents. Favourable parents wanted to protect their sons from disease and found gender equality important. Parents in doubt about male HPV vaccination needed more information about HPV diseases in men and male HPV vaccination; Rejecting parents were generally sceptical of vaccines and feared vaccination side-effects. Parents in countries with active vaccination policies (UK and Italy) tended to trust the importance of national vaccination programmes. Parents in countries with passive vaccination strategies (Germany and France) had greater need for information from health care professionals (HCP) and public health authorities. Conclusion Given brief information about HPV in both genders, parental acceptance of HPV vaccination of sons is as high as acceptance levels for girls. All parents should be informed about HPV to make informed decisions about HPV vaccination for their children. There is a need for joint efforts from public health authorities and HCPs to provide parents with such information. Electronic supplementary material The online version of this article (doi:10.1186/s12889-015-1863-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
| | - Marjorie Adam
- Sanofi Pasteur MSD, 8, rue Jonas Salk, 69367, Lyon, Cedex 07, France.
| | - Laïla Idtaleb
- Ipsos Healthcare, 35 rue du Val de Marne, 75 628, Paris, Cedex 13, France.
| |
Collapse
|
104
|
Perez S, Shapiro GK, Brown CA, Dube E, Ogilvie G, Rosberger Z. 'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons. Psychooncology 2015; 24:1316-1323. [PMID: 26152776 DOI: 10.1002/pon.3894] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2014] [Revised: 05/26/2015] [Accepted: 06/02/2015] [Indexed: 11/07/2022]
Abstract
OBJECTIVE The study's objective was to examine parents' reasons for their decision to vaccinate their 9-16-year-old sons with the human papillomavirus (HPV) vaccine. METHODS Using the precaution adoption process model (PAPM), parents were classified according to one of six stages of decision making: unaware, unengaged, undecided, decided not to vaccinate, decided to vaccinate, or vaccinated. Parents responded to an open-ended question: 'What would influence your decision to have your son vaccinated or not against HPV?' RESULTS Three thousand one hundred and seventeen parents provided 2,874 interpretable narrative responses that were coded using thematic content analyses. The majority of parents were in the earlier precaution adoption process model stages, that is, unaware that the HPV vaccine could be given to boys (57.0%), unengaged (20.9%), or undecided (9.1%). Needing more information, vaccine cost, risks associated with vaccination, and wanting a doctor's recommendation influenced these earlier-staged parents' decisions. Parents who decided not to vaccinate their sons (6.8%) reported their decision was due to the risks, insufficient research, lack of confidence in vaccines, and/or no need for the vaccine (as their sons are not sexually active and/or too young). Parents who had decided to vaccinate their sons (5.0%) or who had vaccinated their sons (1.1%) reported that their decisions were based on protecting their sons' health and preventing disease. CONCLUSION There are important differences in the factors that influence parents' decision depending on where they are along the decision-making trajectory. Assuring that parents are well informed about the importance of male vaccination, reducing vaccine cost, accurately communicating vaccine safety, and improving patient-provider communication may augment vaccine coverage and prevent HPV-associated cancers in Canada. Copyright © 2015 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Samara Perez
- Department of Psychology, McGill University, Montreal, QC, Canada.,Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
| | - Gilla K Shapiro
- Department of Psychology, McGill University, Montreal, QC, Canada.,Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
| | - Christopher A Brown
- Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
| | - Eve Dube
- Institut National de Santé Publique du Québec, Québec, QC, Canada
| | - Gina Ogilvie
- Clinical Prevention Services, BC Centre for Disease Control, Vancouver, BC, Canada.,School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
| | - Zeev Rosberger
- Department of Psychology, McGill University, Montreal, QC, Canada.,Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.,Louise Granofsky Psychosocial Oncology Program, Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada.,Department of Oncology, McGill University, Montreal, QC, Canada
| |
Collapse
|
105
|
Mitos y realidades de la vacunación contra el virus del papiloma humano. GACETA MEXICANA DE ONCOLOGÍA 2015. [DOI: 10.1016/j.gamo.2015.10.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
106
|
Rickert VI, Auslander BA, Cox DS, Rosenthal SL, Rupp RE, Zimet GD. School-based HPV immunization of young adolescents: Effects of two brief health interventions. Hum Vaccin Immunother 2015. [DOI: 10.1080/21645515.2014.1004022 10.1080/21645515.2014.1004022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/12/2022] Open
|
107
|
Yilmazel G, Duman NB. Knowledge, attitudes and beliefs about cervical cancer and human papilloma virus vaccination with related factors in Turkish university students. Asian Pac J Cancer Prev 2015; 15:3699-704. [PMID: 24870780 DOI: 10.7314/apjcp.2014.15.8.3699] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND This study aimed to determine knowledge, attitudes and believes about cervical cancer and human papilloma virus (HPV) vaccination with related factors in Turkish university students. MATERIALS AND METHODS This descriptive and cross sectional study was conducted between June-July 2013 in Hitit University located in Corum, a rural area to the East of Ankara. The population consisted of 550 university students who were training in first and last year from Faculties of Economics, Theology and Health. We reached 463 volunteer students without selection. The study of data was collected with a 44 item questionaire covering socio-demographic features, knowledge, attitudes and beliefs about cervical cancer, HPV and vaccination. Also for this study ethic committee report was taken from Bozok University. Data were evaluated with the SPSS 17.0 programme using the Ki kare test with P<0.05 accepted as statistically significant. RESULTS It was seen that there was a statistically significant variation between classrooms and departments of students with knowledge about cervical cancer and human papilloma virus and vaccine (p<0.001; p<0.01; p<0.05). Also we found low attitudes to thinking about taking HPV vaccination of girls and their children in the future. CONCLUSIONS In light of the study findings; it was concluded that knowledge levels, beliefs and attitudes of the university students about cervical cancer, HPV infection and HPV vaccination were low.
Collapse
Affiliation(s)
- Gulay Yilmazel
- Department of Public Health, Health School, Hitit University, Corum, Turkey E-mail : ;
| | | |
Collapse
|
108
|
Rickert VI, Auslander BA, Cox DS, Rosenthal SL, Rupp RE, Zimet GD. School-based HPV immunization of young adolescents: effects of two brief health interventions. Hum Vaccin Immunother 2015; 11:315-21. [PMID: 25692717 PMCID: PMC4514159 DOI: 10.1080/21645515.2014.1004022] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2014] [Revised: 10/07/2014] [Accepted: 10/18/2014] [Indexed: 10/23/2022] Open
Abstract
Adolescent immunization rates for human papillomavirus (HPV) are low and interventions within school-based health centers (SBHCs) may increase HPV uptake and series completion. We examined the effect of a parent health message intervention on HPV vaccination intent, first dose uptake and series completion among adolescents who received care at SBHCs. Via computer-assisted telephone interviews (CATI), 445 parents of young adolescents were randomly assigned to 2 two-level interventions using a 2 × 2 design (rhetorical question (RQ) or no-RQ and one-sided or two-sided message). The RQ intervention involved asking the parent a question they were likely to endorse (e.g., "Do you want to protect your daughter from cervical cancer?") with the expectation that they would then behave in a manner consistent with their endorsement (i.e., agree to vaccinate). For the one-sided message, parents were given information that emphasized the safety and effectiveness of HPV vaccine, whereas the two-sided message acknowledged that some parents might have concerns about the vaccine, followed by reassurance regarding the safety and effectiveness. At CATI conclusion, parents indicated intentions to have their adolescents vaccinated. Parents who endorsed any intent were sent a consent form to return and all adolescents with signed returned consents were vaccinated at SBHCs. Medical records were reviewed for uptake/completion. Parents were 87% female; adolescents were 66% male and racially/ethnically diverse. 42.5% of parents indicated some intention to immunize, 51.4% were unsure, and 6.1% were not interested. 34% (n = 151) of adolescents received their first dose with series completion rates of 67% (n = 101). The RQ component of the intervention increased intention to vaccinate (RR = 1.45; 95%CI 1.16,1.81), but not first dose uptake or series completion. The 1-sided and 2-sided messages had no effect. This brief, RQ health intervention enhanced intent, but did not impact vaccination rates, likely due to the time delay between the intervention and consent form receipt.
Collapse
Affiliation(s)
| | - Beth A Auslander
- University of Texas Medical Branch at Galveston; Galveston, TX USA
| | - Dena S Cox
- Kelley School of Business; Indiana University; Indianapolis, IN USA
| | - Susan L Rosenthal
- Columbia College of Physician and Surgeons and New York Presbyterian Morgan Stanley Children's Hospital; New York, NY USA
| | - Richard E Rupp
- University of Texas Medical Branch at Galveston; Galveston, TX USA
| | | |
Collapse
|
109
|
Krawczyk A, Knäuper B, Gilca V, Dubé E, Perez S, Joyal-Desmarais K, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Hum Vaccin Immunother 2015; 11:322-9. [PMID: 25692455 PMCID: PMC4514251 DOI: 10.1080/21645515.2014.1004030] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Revised: 10/14/2014] [Accepted: 10/24/2014] [Indexed: 10/23/2022] Open
Abstract
Vaccination against the human papillomavirus (HPV) is an effective primary prevention measure for HPV-related diseases. For children and young adolescents, the uptake of the vaccine is contingent on parental consent. This study sought to identify key differences between parents who obtain (acceptors) and parents who refuse (non-acceptors) the HPV vaccine for their daughters. In the context of a free, universal, school-based HPV vaccination program in Québec, 774 parents of 9-10 year-old girls completed and returned a questionnaire by mail. The questionnaire was based on the theoretical constructs of the Health Belief Model (HBM), along with constructs from other theoretical frameworks. Of the 774 parents, 88.2% reported their daughter having received the HPV vaccine. Perceived susceptibility of daughters to HPV infection, perceived benefits of the vaccine, perceived barriers (including safety of the vaccine), and cues to action significantly distinguished between parents whose daughters had received the HPV vaccine and those whose daughters had not. Other significant factors associated with daughter vaccine uptake were parents' general vaccination attitudes, anticipated regret, adherence to other routinely recommended vaccines, social norms, and positive media influence. The results of this study identify a number of important correlates related to parents' decisions to accept or refuse the HPV vaccine uptake for their daughters. Future work may benefit from targeting such factors and incorporating other health behavior theories in the design of effective HPV vaccine uptake interventions.
Collapse
Key Words
- CAIQ, Commission d’Accès à l’Information du Québec
- CI, Confidence Interval
- GW, Genital Warts
- HBM, Health Belief Model
- HL, Hosmer-Lemeshow
- HPV, Human Papillomavirus
- Human papillomavirus
- OR, Odds Ratio
- RAMQ, Régie de l’Assurance Maladie du Québec
- STI, Sexually Transmitted Infection
- US, United States
- cancer vaccine
- decision-making
- papillomavirus vaccine
- quantitative research
- social determinants of health
- vaccine attitudes
Collapse
Affiliation(s)
- Andrea Krawczyk
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
| | - Bärbel Knäuper
- Department of Psychology; McGill University; Montreal, QC, Canada
| | - Vladimir Gilca
- Institut national de santé publique du Québec; Québec City, QC, Canada
| | - Eve Dubé
- Institut national de santé publique du Québec; Québec City, QC, Canada
| | - Samara Perez
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
| | - Keven Joyal-Desmarais
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
| | - Zeev Rosberger
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
- Louise Granofsky Psychosocial Oncology Program; Segal Cancer Center; Jewish General Hospital; Montreal, QC, Canada
- Departments of Oncology & Psychiatry; McGill University; Montreal, QC, Canada
| |
Collapse
|
110
|
Krawczyk A, Perez S, King L, Vivion M, Dubé E, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother 2015; 11:330-6. [PMID: 25692507 PMCID: PMC4514412 DOI: 10.4161/21645515.2014.980708] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Revised: 09/08/2014] [Accepted: 09/17/2014] [Indexed: 02/06/2023] Open
Abstract
The goal of the study was to examine the reasons given by parents who accepted or refused the HPV vaccine for their daughters in the context of a free provincial school-based vaccination program. A random sample of parents of 9-10 y old girls completed a mail-in questionnaire. Parents' responses to 2 open-ended questions were assessed using content analysis. Coding themes were derived from the Health Belief Model. 806 parents returned and answered the relevant items. 88% of these parents decided to vaccinate their daughter. The primary reasons for parents' acceptance was the perceived benefits (e.g., health protection, cancer/HPV prevention) and cues to action (e.g., physician recommendation, trusting the school vaccine program). Reasons for parental refusal included barriers (e.g., fear of side effects) and low susceptibility (e.g., their daughter is not at risk). Both groups of parents had unanswered questions, doubts and often inaccurate information. This study provides unique insight into parents' perspectives concerning the decision making process for their daughter. There appears to be a need for accurate and complete information to assure informed HPV vaccine decision-making by parents and to increase HPV vaccine uptake.
Collapse
Affiliation(s)
- Andrea Krawczyk
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
| | - Samara Perez
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
| | - Leonora King
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
- Department of Psychiatry; McGill University; Montreal, QC, Canada
| | - Maryline Vivion
- Institut national de santé publique du Québec; Québec City, QC, Canada
| | - Eve Dubé
- Institut national de santé publique du Québec; Québec City, QC, Canada
| | - Zeev Rosberger
- Department of Psychology; McGill University; Montreal, QC, Canada
- Lady Davis Institute for Medical Research; Jewish General Hospital; Montreal, QC, Canada
- Department of Psychiatry; McGill University; Montreal, QC, Canada
- Louise Granofsky Psychosocial Oncology Program; Segal Cancer Center; Jewish General Hospital; Montreal, QC, Canada
- Department of Oncology; McGill University; Montreal, QC, Canada
| |
Collapse
|
111
|
Vermandere H, Naanyu V, Mabeya H, Vanden Broeck D, Michielsen K, Degomme O. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One 2014; 9:e109353. [PMID: 25299646 PMCID: PMC4192319 DOI: 10.1371/journal.pone.0109353] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2014] [Accepted: 09/01/2014] [Indexed: 11/18/2022] Open
Abstract
The development of Human Papillomavirus (HPV) vaccines provides new opportunities in the fight against cervical cancer. Many acceptability studies have revealed high interest in these vaccines, but acceptance is only a precursor of behavior, and many factors, at personal, community and provider level, may inhibit the translation of willingness to vaccinate into actual uptake. Through a longitudinal study in Eldoret, Kenya, HPV vaccine acceptability was measured before a vaccination program (n = 287) and vaccine uptake, as reported by mothers, once the program was finished (n = 256). In between baseline and follow-up, a pilot HPV vaccination program was implemented via the GARDASIL Access Program, in which parents could have their daughter vaccinated for free at the referral hospital. The program was promoted at schools: Health staff informed teachers who were then asked to inform students and parents. Even though baseline acceptance was very high (88.1%), only 31.1% of the women reported at follow-up that their daughter had been vaccinated. The vaccine was declined by 17.7%, while another 51.2% had wanted the vaccination but were obstructed by practical barriers. Being well-informed about the program and baseline awareness of cervical cancer were independently associated with vaccine uptake, while baseline acceptance was correlated in bivariate analysis. Side effects were of great concern, even among those whose daughter was vaccinated. Possible partner disapproval lowered acceptance at baseline, and women indeed reported at follow-up that they had encountered his opposition. In Kenya, women prove to be very willing to have their daughter vaccinated against cervical cancer. However, in this study, uptake was more determined by program awareness than by HPV vaccine acceptance. School-based vaccination might improve coverage since it reduces operational problems for parents. In addition, future HPV vaccination campaigns should address concerns about side effects, targeting men and women, given both their involvement in HPV vaccination decision-making.
Collapse
Affiliation(s)
- Heleen Vermandere
- International Centre for Reproductive Health, Ghent University, Ghent, Belgium
| | - Violet Naanyu
- Department of Behavioral Sciences, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya
| | - Hillary Mabeya
- Department of Reproductive Health, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya
| | - Davy Vanden Broeck
- International Centre for Reproductive Health, Ghent University, Ghent, Belgium
| | - Kristien Michielsen
- International Centre for Reproductive Health, Ghent University, Ghent, Belgium
| | - Olivier Degomme
- International Centre for Reproductive Health, Ghent University, Ghent, Belgium
| |
Collapse
|
112
|
Bhatta MP, Phillips L. Human Papillomavirus Vaccine Awareness, Uptake, and Parental and Health Care Provider Communication Among 11- to 18-Year-Old Adolescents in a Rural Appalachian Ohio County in the United States. J Rural Health 2014; 31:67-75. [PMID: 25040612 DOI: 10.1111/jrh.12079] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- Madhav P. Bhatta
- Department of Biostatistics, Environmental Health Sciences and Epidemiology; College of Public Health, Kent State University; Kent Ohio
| | - Lynette Phillips
- Department of Biostatistics, Environmental Health Sciences and Epidemiology; College of Public Health, Kent State University; Kent Ohio
| |
Collapse
|
113
|
Grandahl M, Tydén T, Rosenblad A, Oscarsson M, Nevéus T, Stenhammar C. School nurses' attitudes and experiences regarding the human papillomavirus vaccination programme in Sweden: a population-based survey. BMC Public Health 2014; 14:540. [PMID: 24886332 PMCID: PMC4061918 DOI: 10.1186/1471-2458-14-540] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2014] [Accepted: 05/23/2014] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Sweden introduced a school-based human papillomavirus (HPV) vaccination programme in 2012, and school nurses are responsible for managing the vaccinations. The aim of the present study was to investigate the attitudes and experiences of school nurses regarding the school-based HPV vaccination programme 1 year after its implementation. METHODS Data were collected using a web-based questionnaire in the spring of 2013, and 83.1% (851/1024) of nurses responded. RESULTS There were strong associations between the nurses' education about the HPV vaccine and their perceived knowledge about the vaccine and a favourable attitude towards vaccination (both p < 0.001). School nurses who received a high level of education were more likely to have a positive attitude to HPV vaccination compared with nurses with little education about HPV vaccination (adjusted odds ratio [OR] = 9.8; 95% confidence interval [CI]: 3.797-25.132). Nurses with high perceived knowledge were more likely to have a positive attitude compared with those with a low level of perceived knowledge (OR = 2.5; 95% CI: 1.299-4.955). If financial support from the government was used to fund an additional school nurse, nurses were more likely to have a positive attitude than if the financial support was not used to cover the extra expenses incurred by the HPV vaccination (OR = 2.1; 95% CI: 1.051-4.010). The majority, 648 (76.1%), had been contacted by parents with questions about the vaccine, mostly related to adverse effects. In addition, 570 (66.9%) stated that they had experienced difficulties with the vaccinations, and 337 (59.1%) of these considered the task to be time-consuming. CONCLUSIONS A high level of education and perceived good knowledge about HPV are associated with a positive attitude of school nurses to the HPV vaccination programme. Thus, nurses require adequate knowledge, education, skills and time to address the questions and concerns of parents, as well as providing information about HPV. Strategic financial support is required because HPV vaccination is a complex and time-consuming task.
Collapse
Affiliation(s)
- Maria Grandahl
- Department of Public Health and Caring Sciences, Uppsala University, Box 564, SE-751 22 Uppsala, Sweden.
| | | | | | | | | | | |
Collapse
|
114
|
Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine 2014; 32:3883-5. [PMID: 24844150 DOI: 10.1016/j.vaccine.2014.05.035] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2014] [Revised: 05/06/2014] [Accepted: 05/07/2014] [Indexed: 11/21/2022]
Abstract
Routine administration of the quadrivalent human papillomavirus (HPV) vaccine has been recommended for 11-12-year-old males since 2011, but coverage remains low. In a U.S. national sample of parents of 11-17-year-old males (n=779), 78.6% of parents reported their sons had not received the HPV vaccine. The most common reason for non-vaccination (56.7%) was "My doctor or healthcare provider has not recommended it." Parents citing only logistical reasons for non-vaccination (e.g., lack of recommendation, access, or education, n=384) reported significantly higher vaccine acceptability than parents reporting a combination of attitudinal (e.g., concerns about vaccine safety or efficacy) and logistical barriers (n=92), while parents citing only attitudinal barriers (n=73) reported the lowest level of vaccine acceptability. In sum, many parents are willing but have not vaccinated sons due to logistical barriers, most commonly lack of healthcare provider recommendation. These findings have important implications for increasing HPV vaccination coverage among adolescent males.
Collapse
|
115
|
Wakimizu R, Nishigaki K, Fujioka H, Maehara K, Kuroki H, Saito T, Uduki K. How adolescent Japanese girls arrive at human papilloma virus vaccination: A semistructured interview study. Nurs Health Sci 2014; 17:15-25. [DOI: 10.1111/nhs.12123] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2013] [Revised: 11/28/2013] [Accepted: 11/29/2013] [Indexed: 11/27/2022]
Affiliation(s)
- Rie Wakimizu
- Faculty of Medicine; University of Tsukuba; Tsukuba Japan
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
| | - Kaori Nishigaki
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- Faculty of Health Sciences; Tsukuba International University; Tsukuba Japan
| | - Hiroshi Fujioka
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- MAEHARA Pediatric Clinic; Tokyo Japan
| | - Koji Maehara
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- SOTOBO Children's Clinic; Chiba Japan
| | - Haruo Kuroki
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- Department of Pediatrics; TAKO Central Hospital; Chiba Japan
| | - Tadashi Saito
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- SHIROAMU Pediatric Clinic; Kushiro Japan
| | - Katsuya Uduki
- Faculty of Health Sciences; Tokyo Healthcare University; Tsukuba Japan
- Investigative Commission of Qualitative Study; Society of Ambulatory and General Pediatrics of Japan; Tokyo Japan
| |
Collapse
|
116
|
Mayhew A, Mullins TLK, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics 2014; 133:404-11. [PMID: 24488747 PMCID: PMC3934341 DOI: 10.1542/peds.2013-2822] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVES Concerns have been raised that human papillomavirus (HPV) vaccination could lead to altered risk perceptions and an increase in risky sexual behaviors among adolescents. The aim of this study was to assess whether adolescent risk perceptions after the first vaccine dose predicted subsequent sexual behaviors. METHODS Young women 13 to 21 years of age (N = 339) completed questionnaires immediately after HPV vaccination, and 2 and 6 months later, assessing demographic characteristics, knowledge/attitudes about HPV vaccination, risk perceptions, and sexual behaviors. Risk perceptions were measured by using 2 5-item scales assessing: (1) perceived risk of sexually transmitted infections (STI) other than HPV, and (2) perceived need for safer sexual behaviors after HPV vaccination. We assessed associations between risk perceptions at baseline and sexual behaviors over the next 6 months by using logistic regression, stratifying participants by sexual experience at baseline and age (13-15 vs. 16-21 years). RESULTS Among all sexually inexperienced participants (42.5%), baseline risk perceptions were not associated with subsequent sexual initiation; in age-stratified analyses, girls 16 to 21 years of age who reported lower perceived risk for other STI (an inappropriate perception) were less likely to initiate sex (odds ratio [OR] 0.13, 95% confidence interval [CI] 0.03-0.69). Among all sexually experienced participants (57.5%) and in age-stratified analyses, baseline risk perceptions were not associated with subsequent number of sexual partners or condom use. CONCLUSIONS Risk perceptions after HPV vaccination were not associated with riskier sexual behaviors over the subsequent 6 months in this study sample.
Collapse
Affiliation(s)
- Allison Mayhew
- University of Cincinnati College of Medicine, Cincinnati, Ohio
| | - Tanya L. Kowalczyk Mullins
- University of Cincinnati College of Medicine, Cincinnati, Ohio;,Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
| | - Lili Ding
- Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
| | - Susan L. Rosenthal
- Department of Pediatrics, Columbia University Medical Center and New York-Presbyterian Morgan Stanley Children's Hospital, New York, New York; and
| | - Gregory D. Zimet
- Department of Pediatrics, Indiana University, Indianapolis, Indiana
| | - Charlene Morrow
- Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
| | - Jessica A. Kahn
- University of Cincinnati College of Medicine, Cincinnati, Ohio;,Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
| |
Collapse
|
117
|
Introduction to the Special Section: Cross-Cultural Beliefs, Attitudes, and Dilemmas About Vaccination. Int J Behav Med 2014; 21:1-2. [DOI: 10.1007/s12529-013-9383-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
118
|
Application of the Carolina Framework for Cervical Cancer Prevention. Gynecol Oncol 2013; 132 Suppl 1:S33-40. [PMID: 24333357 DOI: 10.1016/j.ygyno.2013.12.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Revised: 11/22/2013] [Accepted: 12/02/2013] [Indexed: 11/20/2022]
Abstract
OBJECTIVE The Carolina Framework for Cervical Cancer Prevention describes 4 main causes of cervical cancer incidence: human papillomavirus (HPV) infection, lack of screening, screening errors, and not receiving follow-up care. We present 2 applications of the Carolina Framework in which we identify high-need counties in North Carolina and generate recommendations for improving prevention efforts. METHODS We created a cervical cancer prevention need index (CCPNI) that ranked counties on cervical cancer mortality, HPV vaccine initiation and completion, Pap smear screening, and provision of Pap tests to rarely- or never-screened women. In addition, we conducted in-depth interviews with 19 key informants from programs and agencies involved in cervical cancer prevention in North Carolina. RESULTS North Carolina's 100 counties varied widely on individual CCPNI components, including annual cervical cancer mortality (median 2.7/100,000 women; range 0.0-8.0), adolescent girls' HPV vaccine initiation (median 42%; range 15%-62%), and Pap testing in the previous 3 years among Medicaid-insured adult women (median 59%; range 40%-83%). Counties with the greatest prevention needs formed 2 distinct clusters in the northeast and south-central regions of the state. Interviews generated 9 recommendations to improve cervical cancer prevention in North Carolina, identifying applications to specific programs and policies in the state. CONCLUSIONS This study found striking geographic disparities in cervical cancer prevention need in North Carolina. Future prevention efforts in the state should prioritize high-need regions as well as recommended strategies and applications in existing programs. Other states can use the Carolina Framework to increase the impact of their cervical cancer prevention efforts.
Collapse
|
119
|
Papagiannis D, Rachiotis G, Symvoulakis EK, Daponte A, Grivea IN, Syrogiannopoulos GA, Hadjichristodoulou C. Vaccination against human papillomavirus among 865 female students from the health professions in central Greece: a questionnaire-based cross-sectional study. J Multidiscip Healthc 2013; 6:435-9. [PMID: 24324338 PMCID: PMC3855014 DOI: 10.2147/jmdh.s49558] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
BACKGROUND There are still sparse data on vaccination coverage against human papillomavirus (HPV) among students in the health professions. The aim of this study was to investigate HPV vaccination coverage in female students from the health professions in Greece. METHODS A self-administered, anonymous questionnaire was distributed to second-year and third-year female students pursuing degrees in medicine, nursing, and paramedical health disciplines in central Greece. RESULTS Overall vaccination coverage was 44.3%. The major reason for lack of vaccination was fear about safety of the vaccine. Participants who had received information about safety of the vaccine from the mass media and paramedical students had lower vaccination coverage in comparison with students who had received information about vaccine safety from alternative sources. CONCLUSION Further quantitative and qualitative research is needed to design educational activities targeting female students in the health professions in order to create a positive domino effect and improve HPV vaccination coverage levels in Greece.
Collapse
Affiliation(s)
- Dimitrios Papagiannis
- Department of Hygiene and Epidemiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Thessalia, Greece
| | - George Rachiotis
- Department of Hygiene and Epidemiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Thessalia, Greece
| | | | - Alexandros Daponte
- Department of Obstetrics and Gynaecology, University of Thessalia Medical School, Thessalia, Greece
| | - Ioanna N Grivea
- Department of Paediatrics, University of Thessaly, School of Medicine, General University Hospital of Larissa, Thessalia, Greece
| | - George A Syrogiannopoulos
- Department of Paediatrics, University of Thessaly, School of Medicine, General University Hospital of Larissa, Thessalia, Greece
| | - Christos Hadjichristodoulou
- Department of Hygiene and Epidemiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Thessalia, Greece
| |
Collapse
|
120
|
Zimet GD, Buffler P. Prevention of human papillomavirus-related diseases: Impediments to progress. Prev Med 2013; 57:407-8. [PMID: 23954187 DOI: 10.1016/j.ypmed.2013.08.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2013] [Accepted: 08/03/2013] [Indexed: 01/18/2023]
Affiliation(s)
- Gregory D Zimet
- Section of Adolescent Medicine, Department of Pediatrics, Indiana University School of Medicine, 410 W. 10th St., HS1001, Indianapolis, IN 46202, USA.
| | | |
Collapse
|
121
|
Ojha RP, Jackson BE, Tota JE, Offutt-Powell TN, Singh KP, Bae S. Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States. Hum Vaccin Immunother 2013; 10:232-7. [PMID: 24013368 DOI: 10.4161/hv.26292] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Post-marketing surveillance studies provide conflicting evidence about whether Guillain-Barre syndrome occurs more frequently following quadrivalent human papillomavirus (HPV4) vaccination. We aimed to assess whether Guillain-Barre syndrome is reported more frequently following HPV4 vaccination than other vaccinations among females and males aged 9 to 26 y in the United States. We used adverse event reports received by the United States Vaccine Adverse Event Reporting System (VAERS) between January 1, 2010 and December 31, 2012 to estimate overall, age-, and sex-specific proportional reporting ratios (PRRs) and corresponding Χ2 values for reports of Guillain-Barre syndrome between 5 and 42 d following HPV vaccination. Minimum criteria for a signal using this approach are 3 or more cases, PRR≥2, and Χ2≥4. Guillain-Barre syndrome was listed as an adverse event in 45 of 14,822 reports, of which 9 reports followed HPV4 vaccination and 36 reports followed all other vaccines. The overall, age-, and sex-specific PRR estimates were uniformly below 1. In addition, the overall, age-, and sex-specific Χ2 values were uniformly below 3. Our analysis of post-marketing surveillance data does not suggest that Guillain-Barre syndrome is reported more frequently following HPV4 vaccination than other vaccinations among vaccine-eligible females or males in the United States. Our findings may be useful when discussing the risks and benefits of HPV4 vaccination.
Collapse
Affiliation(s)
- Rohit P Ojha
- Department of Epidemiology and Cancer Control; St. Jude Children's Research Hospital; Memphis, TN USA
| | - Bradford E Jackson
- Division of Preventive Medicine; Department of Medicine; University of Alabama at Birmingham; Birmingham, AL USA
| | - Joseph E Tota
- Division of Cancer Epidemiology; Department of Epidemiology; Biostatistics, and Occupational Health; McGill University; Montreal, QC Canada
| | - Tabatha N Offutt-Powell
- Office of Infectious Disease Epidemiology; Delaware Health and Social Services; Dover, DE USA
| | - Karan P Singh
- Division of Preventive Medicine; Department of Medicine; University of Alabama at Birmingham; Birmingham, AL USA
| | - Sejong Bae
- Division of Preventive Medicine; Department of Medicine; University of Alabama at Birmingham; Birmingham, AL USA
| |
Collapse
|